PRCC and kidney cancer: Herein, we fully characterize the whole genome and DNA methylation of pRCC and rarer kidney cancer subtypes, specifically examining both the core and periphery of selected tumors and, when available, metastatic lesions in order to investigate ITH and clonal evolution.